Reduction of Risk Factors for Cardiovascular Complications by BM 17.0744
- 7 June 2006
- journal article
- Published by Wiley in Cardiovascular Drug Reviews
- Vol. 17 (3) , 246-264
- https://doi.org/10.1111/j.1527-3466.1999.tb00018.x
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Thiazolidinediones: a new class of antidiabetic drugsDiabetic Medicine, 1999
- Acute non‐insulin‐like stimulation of rat muscle glucose metabolism by troglitazone in vitroBritish Journal of Pharmacology, 1997
- Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat.Endocrinology, 1996
- Hepatic peroxisome proliferation in rodents and its significance for humansFood and Chemical Toxicology, 1993
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Prevention of Type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise The 6-year Malm feasibility studyDiabetologia, 1991
- Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-upDiabetologia, 1991
- Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular DiseaseDiabetes Care, 1991
- In vitro studies on the action of CS-045, a new antidiabetic agentMetabolism, 1990
- THE SHORT‐ AND LONG‐TERM EFFECTS OF BEZAFIBRATE IN THE RAT*Annals of the New York Academy of Sciences, 1982